Circulating IL-17(+) β-cell-specific autoreactive CD4 T-cells are a feature of type 1 diabetes diagnosis.
We disclose a novel pathway to β-cell death involving IL-17 and STAT1 and NF-κB, rendering this cytokine a novel disease biomarker and potential therapeutic target.
2011-07-26
Eng.
Department of Immunobiology, School of Medicine, King’s College London, London, UK.
Diabetes. 2011 Aug;60(8):2112-9
© Galenicom 1999-2013